Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus

NCT02536261 is registered in ClinicalTrials.gov with Zhebao Wu as lead sponsor.

NCT NCT02536261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Lead sponsor
Zhebao Wu
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2016
Completion date
Not reported
Enrollment
30 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

invasive prolactinomas involving the cavernous sinus